Liquidia Corp — Director's Dealing 2020

Nov 19, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Liquidia Corp (LQDA)
CIK: 0001819576
Period of Report: 2020-11-18

Reporting Person: JEFFS ROGER (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-18	Common Stock	J	1387500	$6.00	Acquired	1387500	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-11-18	Non-Qualified Stock Option (right to buy)	$3.38	A	30000	Acquired	2030-11-18	Common Stock (30000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	12500	Direct
Common Stock	6095	Indirect

Footnotes

F1: The securities are held by Serendipity BioPharma LLC ("Serendipity"). On November 18, 2020, Serendipity acquired the shares of the Issuer's common stock at the closing of that certain merger transaction among the Issuer, RareGen, LLC ("RareGen") and Liquidia Technologies, Inc. ("Liquidia Technologies"), among other parties, pursuant to which, on November 18, 2020, Liquidia Technologies acquired RareGen and each of Liquidia Technologies and RareGen became wholly owned operating subsidiaries of the Issuer. The shares of Issuer common stock were acquired at a deemed price per share equal to $6.00 as consideration for all of Serendipity's equity in RareGen. The Reporting Person is a manager of Serendipity and has sole voting and dispositive power over the Issuer common stock held by Serendipity.

F2: The securities are held by Roger A. Jeffs 2019 GRAT dtd 05/01/2019 (the "Trust"). The Reporting Person is the trustee of the Trust.

F3: The option vests in 36 equal monthly installments, becoming fully vested on November 18, 2023.